6 days Ago By ABMN Staff
UCB SA ( OTCMKTS:UCBJY – Get Free Report )’s share price crossed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $89.80 and traded as low as $84.
33. UCB shares last traded at $85.80, with a volume of 123,782 shares.
UCB Stock Down 0.7 % The stock’s 50 day moving average is $89.80 and its 200-day moving average is $94.
18. The company has a quick ratio of 0.78, a current ratio of 1.
19 and a debt-to-equity ratio of 0.33. UCB Increases Dividend The business also recently declared a dividend, which will be paid on Wednesday, May 14th.
Investors of record on Tuesday, April 29th will be paid a $0.4838 dividend. This is an increase from UCB’s previous dividend of $0.
46. This represents a yield of 0.62%.
The ex-dividend date of this dividend is Monday, April 28th. UCB Company Profile UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.
Featured Articles Receive News & Ratings for UCB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UCB and related companies with MarketBeat.com's FREE daily email newsletter ..
